Lori Craig, APRN
Nurse Practitioner · Oklahoma City, OKNPI 1003468745
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,688 of the $7,987 with a category attached, or 83.7%. 25 manufacturers reported payments, led by Amgen at 28.3% of the total. 2025 is the largest year on record at $4,364, more than ten times the $284 reported in 2021. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $32.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Sobi, Inc$1K
- AstraZeneca$736
- AbbVie$694
- UCB, Inc.$578
- Johnson & Johnson$553
- plus $2K from 19 others
What the payments were for
- Consulting fees$1,14914%
- Food & beverage$6,68884%
- Education$1502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 75 | $2,262 |
| Sobi, Inc | 5 | $1,325 |
| AstraZeneca(2 entities) | 25 | $736 |
| AbbVie | 37 | $694 |
| UCB, Inc. | 25 | $578 |
| Johnson & Johnson | 14 | $553 |
| Novartis | 15 | $367 |
| GSK | 8 | $254 |
| Daiichi Sankyo Inc. | 5 | $165 |
| Lundbeck LLC | 3 | $139 |
| Kyowa Kirin, Inc. | 2 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| E.r. Squibb & Sons, L.L.C. | 5 | $101 |
| Radius Health, Inc. | 5 | $94 |
| Pfizer | 3 | $80 |
| ANI Pharmaceuticals, Inc. | 4 | $79 |
| Biogen | 1 | $60 |
| Aurinia Pharma U.S., Inc. | 3 | $58 |
| Fresenius Kabi USA, LLC | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,987 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 18 | $320 |
| Prednisone | 29 | $75 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Oklahoma City
- Sara GoreOklahoma City$52K
- Russell RoomsOklahoma City$24K
- Grant YoungOklahoma City$15K
- Janelle WagnerOklahoma City$13K
- Stefanie RollinsOklahoma City$13K
- Lacey CampbellOklahoma City$13K
- Stacey Waggoner FisherOklahoma City$9K
- Karie StewartOklahoma City$9K
- Jennifer LewisOklahoma City$6K
- Theresa BachOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.